Predict your next investment

Verrix company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
verrix.com

See what CB Insights has to offer

Founded Year

2013

Stage

Loan | Alive

Total Raised

$8.25M

Last Raised

$250K | 2 yrs ago

About Verrix

Verrix is a San Clemente, Calif.-based medical device company that is developing technologies to protect patients from healthcare-associated infections. The foundational sterility assurance technology, originally discovered at NASA's Jet Propulsion Laboratory, integrates optical physics, chemistry spectroscopy, and molecular biology.

Verrix Headquarter Location

1330 Calle Avanzado

San Clemente, California, 92673,

United States

949-668-1234

Latest Verrix News

Verrix Focuses on Innovation for Sterilization Monitoring at IAHCSMM Annual Conference

May 9, 2019

May 09, 2019 08:46 AM Eastern Daylight Time SAN CLEMENTE, Calif.--( BUSINESS WIRE )-- Verrix , a developer of solutions for rapid and accurate sterilization confirmation, engaged with sterile processing professionals while exhibiting at the recent International Association of Healthcare Central Service Materiel Management 2019 Annual Conference & Expo. Verrix founder and NASA Jet Propulsion Laboratory scientist Adrian Ponce, Ph.D., met with conference attendees to share how the company is developing new solutions for healthcare that leverage “rocket science” technology originally invented at NASA’s Jet Propulsion Laboratory. The Verrix technology is designed to provide sterilization confirmation results with unparalleled speed and accuracy. During the conference, the company asked attendees to share their vision for the future of infection control and patient safety. “Sterile processing professionals are looking for more advanced technology solutions that will simplify and improve workflows for their increasingly complex jobs,” said Cameron Rouns, Verrix CEO. “Their thoughtful comments highlighted our shared vision for a future with zero healthcare-associated infections from preventable causes.” Rouns also noted that a critical component of the IAHCSMM annual conference is the opportunity for central service and sterile processing professionals to attain continuing education credits needed for certification. “Verrix strongly supports continuing education and the advancement of the sterile processing profession, and provided several $500 vouchers during the conference to further the educational needs of members,” he said. “As we look toward the future, we will continue listening to sterile processing professionals, supporting their advancement, and innovating based on their needs.” About Verrix Verrix is a San Clemente, Calif.-based medical device company that is using the most advanced technologies to help protect patients from healthcare-associated infections. The foundational sterility assurance technology, originally discovered at NASA’s Jet Propulsion Laboratory, integrates cutting-edge optical physics, chemistry spectroscopy, and molecular biology. Based on scientific expertise and close partnerships with healthcare professionals, Verrix is developing market-changing solutions for sterility assurance, environmental monitoring, and infection control. Visit www.verrix.com for more information. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Verrix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Verrix is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,867 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.